Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases.

Pathology

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address:

Published: October 2019

We present a case series of atrophic dermatofibrosarcoma protuberans (DFSP) to further characterise its clinical and pathological features. Sixteen cases were enrolled in the study. There were five males and 11 females with a median age of 28 years. The vast majority occurred in the trunk (12/16, 75%), whereas a minority involved the upper limb or limb gird (2/16, 12.5%), and head and neck region (2/16, 12.5%). The most common presentation was a depressed plaque-like lesion with a greyish-red to purplish-blue colour. Histologically, the lesion was dermal-based consisting of monomorphous spindle cells arranged in parallel fascicles with focal areas displaying storiform architecture. In addition, one case showed remarkable hyalinisation of the matrix, two cases contained scattered pigmented dendritic cells and one case had admixed giant cell fibroblastoma-like component, respectively. The diagnosis was confirmed by immunohistochemical study, and by further fluorescence in situ hybridisation analysis in six cases. Follow-up thus far has revealed a relatively low rate of local recurrence (1/10, 10%). Familiarity with the distinctive clinical and pathological features of atrophic DFSP helps avoid misdiagnosis. Like a classical DFSP, morphological variants can also occur in an atrophic DFSP, including pigmented, sclerosing and hybrid subtypes, albeit rare.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2019.06.002DOI Listing

Publication Analysis

Top Keywords

atrophic dermatofibrosarcoma
8
dermatofibrosarcoma protuberans
8
clinical pathological
8
pathological features
8
2/16 125%
8
atrophic dfsp
8
atrophic
4
protuberans clinicopathological
4
clinicopathological study
4
cases
4

Similar Publications

Article Synopsis
  • Dermatofibrosarcoma protuberans (DFSP) with atrophic and pigmentary features (AP-DFSP) is a rare skin condition characterized by lesions mainly on the trunk and limbs, often presenting as depressed, colored plaques.
  • This study analyzed 14 cases of AP-DFSP to determine clinical features, treatment responses, and prognostic outcomes, finding that patients had a mean age of 25 years and most cases were successfully treated with complete surgical excision.
  • Results indicated that AP-DFSP has more benign characteristics compared to standard DFSP, with a high likelihood of complete remission following surgery and no reported local recurrences or metastasis in the studied cases.
View Article and Find Full Text PDF
Article Synopsis
  • Dermatofibrosarcoma protuberans (DFSP) is a rare but locally aggressive skin tumor in children, known for slow growth and low likelihood of spreading, yet it often goes misdiagnosed due to its nonspecific symptoms.
  • Diagnosing DFSP can be difficult because it may present as nodular lesions or resemble other conditions like vascular malformations, highlighting the need for histologic and immunohistochemical examinations.
  • Successful treatment involves complete surgical removal with wide margins, as seen in two pediatric cases where lesions initially mimicked vascular issues, resulting in no recurrences after follow-ups of 6 months and 2 years, with ongoing monitoring planned for at least 5 years.
View Article and Find Full Text PDF
Article Synopsis
  • - A 34-year-old man had a long-standing nodule on his chest, which was diagnosed as atrophic dermatofibrosarcoma protuberans (DFSP) after slow Mohs micrographic surgery (MMS).
  • - MRI showed a large lesion that was in close proximity to the pectoralis major muscle, indicating a significant reconstruction challenge.
  • - The reconstruction involved a rotational flap and synthetic xenogeneic artificial dermis to close a 13 cm x 12 cm defect left after surgery.
View Article and Find Full Text PDF

Background: Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder characterized by skeletal muscle atrophy and weakness. New treatments for SMA have been developed namely, the drugs nusinersen, onasemnogene abeparvovec, and risdiplam. However, there are limited reports on their effects on adult patients with SMA, particularly over long periods.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!